Impact of Laws on Pediatric Opioid Prescriptions
Drug Topics
SEPTEMBER 9, 2022
Are prescription cap laws for opioids effective for children and teenagers?
Fri.Sep 09, 2022
579 
Rejecting ICER’s bad advice
PhRMA
SEPTEMBER 9, 2022
America leads the world in biomedical innovation today because our system rewards investment in research and discovery of new treatments. Now, with the passage of the Inflation Reduction Act , Dr. Steven Pearson, president of the Institute for Clinical and Economic Review (ICER), coolly admits we will see fewer new cures and treatments and suggests that trade-off is one we need to make.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Improving Glycemic Markers in Children with Type 1 Diabetes Using Technology
Drug Topics
SEPTEMBER 9, 2022
Software updates in closed-loop systems may lead to better time in range numbers for children with type 1 diabetes.
Pharmacy Focus: Psychedelic Pharmacy - Understanding Synthetic vs. Natural Psychedelics
Pharmacy Times
SEPTEMBER 9, 2022
Scientists may be able to minimize adverse effects while gaining a better understanding of psychedelic medicines' efficacy and durability.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How Pharmacists Can Address Vaccine Hesitancy for the Flu and Beyond
Drug Topics
SEPTEMBER 9, 2022
Address vaccine hesitancy at your pharmacy to encourage patients and their families to get vaccinated against COVID-19, flu, and more.
Sunvozertinib Meets Primary Endpoint in First Pivotal Study in Platinum-Pretreated NSCLC With EGFR Mutations
Pharmacy Times
SEPTEMBER 9, 2022
Sunvozertinib is an oral, potent EGFR exon20ins inhibitor with wild-type EGFR selectivity.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Novo Nordisk, Kry partner on digital programme for obesity
pharmaphorum
SEPTEMBER 9, 2022
Digital health specialist Kry has teamed up with pharma group Novo Nordisk on the development of resources that can help people with obesity manage their condition and adhere to treatment. The partners anticipate that the digital obesity programme will launch later this autumn in Sweden, ahead of a broader rollout in other European markets before the end of the year.
Fighting Vision Loss: Vabysmo
PharmExec
SEPTEMBER 9, 2022
Use against pair of pathways could pave way for standout in stocked eye disease market.
Kroger reports strong Q2 results, raises full-year guidance
Drug Store News
SEPTEMBER 9, 2022
Kroger's sales reached $34.6 billion in the second quarter, compared to $31.7 billion for the same period last year.
Next-level Efficacy: Mounjaro
PharmExec
SEPTEMBER 9, 2022
Dual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Haus Labs by Lady Gaga optimizes complexions with foundation, setting powder
Drug Store News
SEPTEMBER 9, 2022
New launches from the beauty brand include Triclone Skin Tech Foundation, Bio-Blurring Talc-Free Loose Setting Powder and a foundation brush.
Opinion: Health care’s shift from covenant to commodity comes with consequences
STAT
SEPTEMBER 9, 2022
Norman Rockwell’s 1939 painting “When the Doctor Treats Your Child” depicts a family doctor with a stethoscope around his neck scribbling a prescription in front of three children, one sitting on his mother’s lap. The painting evokes the health care covenant: one doctor responsible for the family as well as for the community, whose professional ethics required unfaltering dedication to their patient’s well-being.
Watch DSN: iA executives discuss the company’s impact on pharmacy industry
Drug Store News
SEPTEMBER 9, 2022
iA’s Alecia Lashier and Tom Utech discuss how the company hopes to revolutionize the pharmacy industry over the next few years.
STAT+: J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review
STAT
SEPTEMBER 9, 2022
In an unusual turn of events, an appeals panel ruled that the U.K.’s cost effectiveness watchdog agency acted unfairly and exceeded its authority by failing to thoroughly explain why it declined to recommend a Johnson & Johnson medicine called Spravato for combating treatment-resistant depression. Specifically, the panel determined that the National Institute for Health and Care Excellence did not thoroughly convey its views on how uncertainties in the evidence that are “inhere
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
COVID-19 has changed clinical trials for the better, says Medidata
pharmaphorum
SEPTEMBER 9, 2022
The pandemic forced clinical trial sponsors to change their processes, with a more technology-driven approach and, according to a new study by Medidata, the sector is now “stronger than ever” as a result. The study , based on interviews conducted earlier this year with 400 clinical trial executives from the UK, France, Germany, and Switzerland, found that more than a third (37%) ranked better outcomes of trials within the top three areas of improvement since COVID-19 emerged.
STAT+: Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money
STAT
SEPTEMBER 9, 2022
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is decidedly modest. We plan to catch up on some reading, putter about the castle, and promenade with the official mascot. And what about you? This remains a fine time of year to enjoy the great outdoors — beaches, lakes, and mountain trails are beckoning.
Teenagers approach educators with mental health concerns more than parents
Drug Store News
SEPTEMBER 9, 2022
A survey conducted by CVS Health Morning Consult found that parents and educators play critical and complementary roles in supporting the mental health of adolescents.
STAT+: Up and down the ladder: The latest comings and goings
STAT
SEPTEMBER 9, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. ( Editor’s note: Our regular feature that focuses on a newly hired executive will return next week).
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Retail health clinics play larger role in consumer health care
Drug Store News
SEPTEMBER 9, 2022
DSN editor and chief Nigel F. Maynard takes a look at how the retail pharmacy industry needs to plan for the next chapter in its storyline.
Assessing HCP-Visit Fallout: COVID’s Ultimate Impact on New Drug Entrants
PharmExec
SEPTEMBER 9, 2022
Tracking the pandemic’s influence on brand awareness and prescribing efforts in light of decline in physician visits and fewer diagnoses—and what these dynamics, still unsettled post-pandemic, might mean for future launches.
Gatehouse Bio and AstraZeneca to develop RNA therapeutics for heart failure
Pharmaceutical Technology
SEPTEMBER 9, 2022
US-based biotech company Gatehouse Bio is extending its collaboration with AstraZeneca for developing RNA therapeutics to treat heart failure with preserved ejection fraction (HFpEF). Initially, the companies partnered to identify new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s artificial intelligence (AI)-powered platform in December 2019.
Amneal appoints executive VP, chief commercial officer of specialty
Drug Store News
SEPTEMBER 9, 2022
Amneal has appointed Gustavo Pesquin as executive vice president, chief commercial officer, specialty, effective Sept. 6.
How Good is a Good Product Launch?
PharmExec
SEPTEMBER 9, 2022
A fresh look at how industry benchmarks can help fortify new drug launches to overcome today’s new market-entry barriers and higher expectations.
BJ’s Wholesale Club opens in Canton, Mich.
Drug Store News
SEPTEMBER 9, 2022
The club opening in Canton marks the retailer’s fourth grand opening in 2022 and fifth location in Michigan.
Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice
Pharmacy Times
SEPTEMBER 9, 2022
About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.
How Much Data Does Pharma Want to Share?
PharmExec
SEPTEMBER 9, 2022
And, in equal measure, patients and doctors—as EU mulls new rules.
Antigen Biomarkers Could Predict Disease Progression of Hospitalized COVID-19 Patients
Pharmacy Times
SEPTEMBER 9, 2022
Viral antigen levels in blood plasma can provide clinically important patient outcomes among hospitalized patients with COVID-19.
Charles River and Cure AP-4 Announce Manufacturing Collaboration
BioPharm
SEPTEMBER 9, 2022
Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.
Study: Olokinzumab As Effective as “Gold Standard” Treatment for Rheumatoid Arthritis
Pharmacy Times
SEPTEMBER 9, 2022
Researchers expect to file for FDA approval within the year following the successful phase 3 trial.
The Biotech Rally Continues—What’s Fueling the Surge?
PharmExec
SEPTEMBER 9, 2022
Biotech stocks and the indexes have staged an impressive recovery.
Study: Three COVID-19 Vaccine Doses May Provide Better, Longer Protection Than Two
Pharmacy Times
SEPTEMBER 9, 2022
Receiving 3 doses of the COVID-19 vaccine can offer better and more long-lasting protection against the Omicron variant.
Where Innovation Meets Commercialization
PharmExec
SEPTEMBER 9, 2022
Pharm Exec releases its annual product launch feature articles.
Study: Refundable State-Level Earned Income Tax Credit Could Decrease High-Risk HIV Behavior
Pharmacy Times
SEPTEMBER 9, 2022
A refundable state-level earned income tax credit was associated with a 21% reduction in high-risk HIV behavior among low-income women last year, suggesting that policy can reduce this burden.
Let's personalize your content